Outcome of Risk-Based Therapy for Infant Acute Lymphoblastic Leukemia With or Without an MLL Gene Rearrangement, With Emphasis on Late Effects: A Final Report of Two Consecutive Studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group

Leukemia - United Kingdom

doi 10.1038/sj.leu.2404903